America will struggle to pay for ultra-expensive gene therapies

T is familiar, the liquid inside could be water—but the price tag is a little more unusual. A shot of Zolgensma, a gene therapy for spinal-muscular atrophy, comes to $2.1m. It is one of a new generation of ultra-expensive medicines. Treatments for beta-thalassemia and haemophilia, two blood…#zolgensma #haemophilia #vertex #medicaid #michaelkleinrock #franciscollins #innovationcentre #zandyforbes #meirax #hepatitis
Source: Reuters: Health - Category: Consumer Health News Source Type: news